Irish Times – Open Orphan to test Covid-19 drug through London subsidiary
Pharma company steps up fight against virus that has infected more than 2.6m worldwide by Ciara O’Brien Dublin-listed pharma services company Open Orphan has begun testing an anti-viral treatment for Covid-19 through its London-based subsidiary Hvivo. The testing is being carried out on behalf of Nearmedic International, a specialist pharmaceutical, biotechnological and medical company headquartered […]
Cadence Minerals #KDNC – European Metals #EMH – CEZ Investment into Cinovec Project Approved.
Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pleased to note the update today from European Metals Holdings Limited (“European Metals” “EMH” or “the Company”) that shareholders have today approved at the General Meeting of the Company, the amended arrangements for the investment of EUR 29.1 million (approximately GBP 25.8 million) by CEZ a.s. (“CEZ”) for […]
Open Orphan #ORPH – Testing of anti-viral for treating COVID-19 underway
Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that its London-based subsidiary hVIVO has commenced the testing of an anti-viral for treating COVID-19 on behalf of […]
Kelsey Hightower: Why modernizing at the infrastructure layer is half the problem – Fedr8
Lifting-and-shifting virtual machines from on-premises to a cloud can treat the application as a fragile black-box. To make this black-box operational in the cloud without adapting it means you have to change the environment — the cloud — to fit the black-box. This is great news for vendors like VMware because they specialise in “normalizing […]
Alan Green talks house builders, Braveheart Investments #BRH, Two Shields Investments #TSI, ECR Minerals #ECR & Catenae #CTEA on UK Investor Mag podcast
Alan Green discusses house builders, Braveheart Investments #BRH, Two Shields Investments #TSI, ECR Minerals #ECR & Catenae #CTEA with Jonathan Roy on the UK Investor Mag podcast.
LocoSoco Group #LOCO – Heart of England Co-operative Society Distribution Arrangement
LocoSoco Group Plc, the Wiener Borse DM traded company that builds technology and products to profit from creating sustainable communities, is pleased to announce a new distribution arrangement with the Heart of England Co-operative Society. Following on from our strong March trading performance announced on April 3rd 2020, LocoSoco have signed a distribution arrangement with […]
Cadence Iron Ore Update – Record Iron Ore production recorded by BHP in latest Operational Review
BHP OPERATIONAL REVIEW FOR NINE MONTHS ENDED 31 MARCH 2020 Our highest priority is the safety, health and wellbeing of our workforce and communities. We have taken action to reduce the spread of COVID-19. Our financial position is strong. Underpinned by our low-cost operations, our business is resilient and expected to continue to generate solid […]
Alan Green talks Braveheart #BRH, Tiziana Life Sciences #TILS, Cadence Minerals #KDNC & ECR Minerals #ECR on Vox Markets podcast
Alan Green discusses Braveheart Investments #BRH, Tiziana Life Sciences #TILS, Cadence Minerals #KDNC & ECR Minerals #ECR with Justin Waite on Vox Markets podcast. Interview is 39 minutes in.
Tiziana Life Sciences – Clinical pipeline update, resolutions seeking shareholder authority to issue new shares for cash & approval of proposed option grant
London, New York 21 April 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), the U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has convened a general meeting (the “GM”) […]
Catenae Innovation #CTEA – Conditional Placing to raise £320,000 and Update
Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, today announces that it has conditionally raised gross proceeds of £320,000 by placing 32,000,000 new ordinary shares (“Placing Shares”) at a price of 1p per share (the “Placing”). The holders of the Placing Shares will receive warrants to subscribe for a […]